151 related articles for article (PubMed ID: 18309229)
1. Antiproliferative effects of GnRH agonists: prospects and problems for cancer therapy.
White CD; Stewart AJ; Lu ZL; Millar RP; Morgan K
Neuroendocrinology; 2008; 88(2):67-79. PubMed ID: 18309229
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
Harrison GS; Wierman ME; Nett TM; Glode LM
Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
[TBL] [Abstract][Full Text] [Related]
3. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.
Gründker C; Emons G
Reprod Biol Endocrinol; 2003 Oct; 1():65. PubMed ID: 14594454
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.
Maudsley S; Davidson L; Pawson AJ; Chan R; López de Maturana R; Millar RP
Cancer Res; 2004 Oct; 64(20):7533-44. PubMed ID: 15492280
[TBL] [Abstract][Full Text] [Related]
5. Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor.
Kraus S; Naor Z; Seger R
Arch Med Res; 2001; 32(6):499-509. PubMed ID: 11750725
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?
Montagnani Marelli M; Moretti RM; Januszkiewicz-Caulier J; Motta M; Limonta P
Curr Cancer Drug Targets; 2006 May; 6(3):257-69. PubMed ID: 16712461
[TBL] [Abstract][Full Text] [Related]
7. GnRH receptor and apoptotic signaling.
Imai A; Tamaya T
Vitam Horm; 2000; 59():1-33. PubMed ID: 10714235
[TBL] [Abstract][Full Text] [Related]
8. Autocrine production of reproductive axis neuropeptides affects proliferation of canine osteosarcoma in vitro.
Weinman MA; Fischer JA; Jacobs DC; Goodall CP; Bracha S; Chappell PE
BMC Cancer; 2019 Feb; 19(1):158. PubMed ID: 30777054
[TBL] [Abstract][Full Text] [Related]
9. Biology of the gonadotropin-releasing hormone system in gynecological cancers.
Gründker C; Günthert AR; Westphalen S; Emons G
Eur J Endocrinol; 2002 Jan; 146(1):1-14. PubMed ID: 11751060
[TBL] [Abstract][Full Text] [Related]
10. The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans.
Limonta P; Moretti RM; Montagnani Marelli M; Motta M
Front Neuroendocrinol; 2003 Dec; 24(4):279-95. PubMed ID: 14726258
[TBL] [Abstract][Full Text] [Related]
11. Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer.
Gnanapragasam VJ; Darby S; Khan MM; Lock WG; Robson CN; Leung HY
J Pathol; 2005 Jun; 206(2):205-13. PubMed ID: 15818594
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory proteins inhibiting cancer cell proliferation.
Tripathi PH; Akhtar J; Arora J; Saran RK; Mishra N; Polisetty RV; Sirdeshmukh R; Gautam P
BMC Cancer; 2022 Feb; 22(1):133. PubMed ID: 35109816
[TBL] [Abstract][Full Text] [Related]
13. Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors.
McArdle CA; Franklin J; Green L; Hislop JN
J Endocrinol; 2002 Apr; 173(1):1-11. PubMed ID: 11927379
[TBL] [Abstract][Full Text] [Related]
14. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
Zhao LJ; Wei LH; Li XP; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
[TBL] [Abstract][Full Text] [Related]
15. Signalling and anti-proliferative effects mediated by gonadotrophin-releasing hormone receptors after expression in prostate cancer cells using recombinant adenovirus.
Franklin J; Hislop J; Flynn A; McArdle CA
J Endocrinol; 2003 Feb; 176(2):275-84. PubMed ID: 12553876
[TBL] [Abstract][Full Text] [Related]
16. Detection of mRNA expression of gonadotropin-releasing hormone and its receptor in normal and neoplastic rat prostates.
Lau HL; Zhu XM; Leung PC; Chan LW; Chen GF; Chan PS; Yu KL; Chan FL
Int J Oncol; 2001 Dec; 19(6):1193-201. PubMed ID: 11713589
[TBL] [Abstract][Full Text] [Related]
17. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.
Szabó I; Bősze S; Orbán E; Sipos É; Halmos G; Kovács M; Mező G
J Pept Sci; 2015 May; 21(5):426-35. PubMed ID: 25908176
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone receptor gene expression during pubertal development of male rats.
Zapatero-Caballero H; Sanchez-Franco F; Guerra-Perez N; Fernandez-Mendez C; Fernandez-Vazquez G
Biol Reprod; 2003 May; 68(5):1764-70. PubMed ID: 12606421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
